(Q61934253)
Statements
A 52-Week, Open-Label, Multicenter Study of the Safety and Tolerability of Aripiprazole Flexibly Dosed in the Treatment of Children and Adolescents With Autistic Disorder (English)
0 references
September 2006
0 references
June 2009
0 references
330
0 references
6 year
0 references
17 year
0 references